Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis

Journal of Microbiology, Immunology and Infection

Volumn 45, Issue 4, 2012, Pages 296-304

  Liao, Chia Hung ^a,b   Chi, Chih Yu ^a   Wang, Yi Jen ^a   Tseng, Shu Wen ^a   Chou, Chia Huei ^a   Ho, Cheng Mao ^a   Lin, Po Chang ^a   Ho, Mao Wang ^a   Wang, Jen Hsian ^a,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b FENG YUAN HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cryptococcus; HIV; Meningitis; Surgery; Taiwan

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; FLUCYTOSINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD CULTURE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CRYPTOCOCCAL MENINGITIS; DEMOGRAPHY; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCEPHALUS; INTRACRANIAL HYPERTENSION; LIVER CIRRHOSIS; LUMBAR PUNCTURE; MALE; MENTAL DISEASE; MORTALITY; OUTCOME ASSESSMENT; PLEOCYTOSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; RELAPSE; RETROSPECTIVE STUDY; SURGICAL DRAINAGE; SYMPTOM; TAIWAN;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; CD4 LYMPHOCYTE COUNT; CRYPTOCOCCUS; FEMALE; FLUCYTOSINE; FOLLOW-UP STUDIES; HIV; HIV INFECTIONS; HUMANS; HYDROCEPHALUS; INTRACRANIAL HYPERTENSION; MALE; MENINGITIS, CRYPTOCOCCAL; RETROSPECTIVE STUDIES; SPINAL PUNCTURE; TAIWAN; TREATMENT OUTCOME;

EID: 84863866487     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2011.12.005     Document Type: Article

References (37)

1. Enache-Angoulvant A., Chandenier J., Symoens F., Lacube P., Bolognini J., Douchet C., et al. Molecular identification of Cryptococcus neoformans serotypes. J Clin Microbiol 2007, 45:1261-1265.
2. Chayakulkeeree M., Perfect J.R. Cryptococcosis. Infect Dis Clin North Am 2006, 20:507-544.
3. Mitchell T.G., Perfect J.R. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995, 8:515-548.
4. Shih C.C., Chen Y.C., Chang S.C., Luh K.T., Hsieh W.C. Cryptococcal meningitis in non-HIV-infected patients. Q J Med 2000, 93:245-251.
5. Bekondi C., Bernede C., Passone N., Minssart P., Kamalo C., Mbolidi D., et al. Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus. Int J Infect Dis 2006, 10:387-395.
6. Park B.J., Wannemuehler K.A., Marston B.J., Govender N., Pappas P.G., Giller T.M. Estimation of the current global burden of cryptococcal meningitis persons living with HIV/AIDS. AIDS 2009, 23:525-530.
7. Ecevit I.Z., Clancy C.J., Schmalfuss I.M., Nguyen M.H. The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: A call for better disease recognition and evaluation of adjuncts to antifungal therapy. Clin Infect Dis 2006, 42:1443-1447.
8. Nguyen M.H., Husain S., Clancy C.J., Peacock J.E., Hung C.C., Kontoyiannis D.P., et al. Outcomes of central nervous system cryptococcosis vary with host immune function: results from a multi-center, prospective study. J Infect 2010, 61:419-426.
9. Jean S.S., Fang C.T., Shau W.Y., Chen Y.C., Chang S.C., Hsueh P.R., et al. Cryptococcaemia: clinical features and prognostic factors. Q J Med 2002, 95:511-518.
10. Lin T.Y., Yeh K.M., Lin J.C., Wang N.C., Peng M.Y., Chang F.Y. Cryptococcal disease in patients with or without human immunodeficiency virus: clinical presentation and monitoring of serum cryptococcal antigen titers. J Microbiol Immunol Infect 2009, 42:220-226.
11. Lee Y.C., Wang J.T., Sun H.Y., Chen Y.C. Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection. J Microbiol Immunol Infect 2011, 44:338-345.
12. Lui G., Lee N., Ip M., Choi K.W., Tso Y.K., Lam E., et al. Cryptococcosis in apparently immunocompetent patients. Q J Med 2006, 99:143-151.
13. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992, 41(No.RR-17):1-19.
14. Saag M.S., Graybill R.J., Larsen R.A., Pappas P.G., Perfect J.R., Powderly W.G., et al. Practice guidelines for the management of Cryptococcal disease. Clin Infect Dis 2000, 30:710-718. for the Mycoses Study Group Cryptococcal Subproject.
15. Perfect J.R., Dismukes W.E., Dromer F., Goldman D.L., Graybill J.R., Hamill R.J., et al. Clinical practice guidelines for the management of Cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis 2010, 50:291-322.
16. Diamond R.D., Bennett J.E. Prognostic factors in cryptococcal meningitis: a study in 111 cases. Ann Intern Med 1974, 80:176-181.
17. Zhu L.P., Wu J.Q., Xu B., Ou X.T., Zhang Q.Q., Weng X.H. Cryptococcal meningitis in non-HIV-infected patients in a Chinese tertiary care hospital, 1997-2007. Med Mycol 2010, 48:570-579.
18. Lu C.H., Chang W.N., Chang H.W., Chuang Y.C. The prognostic factors of cryptococcal meningitis in HIV-negative patients. J Hosp Infect 1999, 42:313-320.
19. Dromer F., Mathoulin-Pelissier S., Launay O., Lortholary O. Determinants of disease presentation and outcome during Cryptococcosis: the CryptoA/D study. PLoS Med 2007, 4:e21. The French Cryptococcosis Study Group.
20. Chang W.C., Tzao C., Hsu H.H., Lee S.C., Huang K.L., Tung H.J. Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients. Chest 2006, 129:333-340.
21. Sun H.Y., Chen M.Y., Hsiao C.F., Hsieh S.M., Hung C.C., Chang S.C. Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active anti-retroviral therapy. Clin Microbiol Infect 2006, 12:381-388.
22. Cheng Y.C., Lirng J.F., Chang F.C., Wang S.J., Fuh J.L., Chen S.S., et al. Radiological manifestations of cryptococcal infection in central nervous system. J Chin Med Assoc 2003, 66:19-26.
23. Sun H.Y., Hung C.C., Chang S.C. Management of cryptococcal meningitis with extremely high intracranial pressure in HIV-infected patients. Clin Infect Dis 2004, 38:1790-1792.
24. Graybill J.R., Sobel J., Saag M., Horst C.M., Powderly W., Cloud G., et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin Infect Dis 2000, 30:47-54.
25. Cachay E.R., Caperna J., Sitapati A.M., Jafari H., Kandel S., Mathews W.C. Utility of clinical assessment, imaging, and cryptococcal antigen titer to predict AIDS-related complicated forms of cryptococcal meningitis. AIDS Res Ther 2010, 7:29.
26. Horst C.M., Saag M.S., Cloud G.A., Hamill R.J., Graybill J.R., Sobel J.D., et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997, 337:15-21.
27. Loyse A., Wainwright H., Jarvis J.N., Bicanic T., Rebe K., Meintjes G., et al. Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure. AIDS 2010, 24:405-410.
28. Jarvis J.N., Harrison T.S. HIV-associated cryptococcal meningitis. AIDS 2007, 21:2119-2129.
29. Antinori S., Ridolfo A.L., Gianelli E., Piazza M., Gervasoni C. The role of lumbar puncture in the management of elevated intracranial pressure in patients with AIDS-associated cryptococcal meningitis. Clin Infect Dis 2000, 31:1309-1310.
30. Lortholary O., Poizat G., Zeller V., Neuville S., Boibieux A., Alvarez M., et al. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. AIDS 2006, 20:2183-2191.
31. Mussini C., Pezzotti P., Miro J.M., Martinez E., Quiros J.C., Cinque P. Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study. Clin Infect Dis 2004, 38:565-571.
32. Corti M., Solari R., Cangelosi D., Dominguez C., Yampolsky C., Negroni R., et al. Sudden blindness due to bilateral optic neuropathy associated with cryptococcal meningitis in an AIDS patient M. Rev Iberoam Micol 2010, 27:207-209.
33. Wang H.C., Chang W.N., Lui C.C., Peng J.P., Huang C.R., Chang H.W., et al. The prognosis of hearing impairment complicating HIV negative cryptococcal meningitis. Neurology 2005, 65:320-322.
34. Mills E.J., Bakanda C., Birungi J., Mwesigwa R., Chan K., Ford N. Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda. AIDS 2011, 25:851-855.
35. Zhang F., Dou Z., Ma Y., Zhang Y., Zhao Y., Zhao D., et al. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis 2011, 11:516-524.
36. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2007, 46:607-615. Antiretroviral Therapy Cohort Collaboration.
37. Chen S., Sorrell T., Nimmo G., Speed B., Currie B., Ellis D., et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect Dis 2000, 31:499-508.